On Thursday, Apple Inc. (NASDAQ:AAPL)’s shares inclined 1.06% to $120.53.
Apple Inc. (AAPL) has beta value of 0.87. The company has the market capitalization of $665.38 billion. Return on assets ratio of the company was 19.70% while its return on equity ratio was 41.50%. ATR value of company was 2.70 while stock volatility for week was 2.47% while for month was 2.04%. Debt to equity ratio of the company was 0.43 and its current ratio was 1.00.
It turns out that Apple’s streaming-TV box — aptly named Apple TV — isn’t just for streaming anymore. Its latest incarnation offers on the big screen just about anything you could formerly only do on an iPhone or iPad, according to Los Angeles Times.
Whether that’s good may depend on whether you really want to buy shoes, browse home listings or read comic books on your TV. The new Apple TV looks to be a capable device for those purposes, although it’s not flawless. Its streaming-TV features also trump those of its predecessor.
The new Apple TV will set you back $149, or $199 for a version with extra storage. Apple will still sell the old version for $69. Neither requires an iPhone or iPad, although either iDevice can simplify the Apple TV setup process. Los Angeles Times Reports.
Apple Inc. (Apple) designs, manufactures and markets mobile communication and media devices, personal computers, and portable digital music players, and a variety of related software, services, peripherals, networking solutions, and third-party digital content and applications.
Gilead Sciences, Inc. (NASDAQ:GILD)’s shares gained 1.00% to $109.21.
Gilead Sciences, Inc. (GILD) is currently valued at $158.69 billion. The company has 1.47 billion shares outstanding and 83.40% shares of the company were owned by institutional investors. The company has 5.49 value in price to sale ratio while price to book ratio was recorded as -9.87. The company exchanged hands with 10.78 million shares as compared to its average daily volume of 13.42 million shares. It beta stands at 0.85.
Gilead Sciences, Inc. (Gilead), is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines. The Company’s primary areas of focus comprise human immunodeficiency virus (HIV), liver diseases such as chronic hepatitis C virus (HCV) infection and chronic hepatitis B virus (HBV) infection, oncology and inflammation, and serious cardiovascular and respiratory conditions.
At the end of Thursday’s trade, Qunar Cayman Islands Ltd (NASDAQ:QUNR)‘s shares surged 6.96% to $46.27.
Qunar Cayman Islands Ltd (QUNR) offered 39.10% EPS for prior five years. The company has 96.30% return on equity value while its ROI ratio was 44.80%. The company has $5.66 billion market capitalizations and the institutional ownership was 83.40%. Its price to book ratio was -9.87. Volatility of the stock was 2.96% for the week while for the month booked as 3.20%.
Qunar Cayman Islands Limited (Qunar) is engaged in offering mobile and online commerce platform for travel in China. The Company offers a range of travel products, counting flights, hotels, vacations packages, attraction tickets and other travel related offerings. The Company has developed Qunar Travel, its mobile application, which enables its users to search for and purchase travel products.